Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD.
M
M
Kennedy
A C
AC
Ford
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use*; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors